Corvus Pharmaceuticals Other Equity Adjustments (Quarterly) Analysis

Corvus Pharmaceuticals, Inc. (CRVS)

17.82 +0.61 (+3.54%) USD | NASDAQ | Feb 24, 16:00

17.73 -0.09 (-0.51%) Pre-Market: 08:59

View Other Equity Adjustments (Quarterly) for CRVS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Equity Adjustments (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Equity Adjustments (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Equity Adjustments (Quarterly) Benchmarks

Start Trial

Regeneron Pharmaceuticals, Inc.	Upgrade
Plus Therapeutics, Inc.	--
Geron Corp.	Upgrade
Jaguar Health, Inc.	Upgrade
Krystal Biotech, Inc.	Upgrade